Definition:
The Wound Care market consists of a comprehensive array of over-the-counter (OTC) solutions. These solutions are aimed at managing wounds, promoting healing, and preventing infections. The product offerings encompass adhesive bandages for minor wound coverage, first aid kits providing extensive supplies, gauze and tape for maintaining cleanliness, as well as wound healing ointments that support the recovery of damaged skin and wounds. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information:
The Wound Care market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
The Wound Care market in Austria is experiencing significant growth and development. Customer preferences for advanced wound care products and the increasing prevalence of chronic wounds are driving this trend. Additionally, local special circumstances, such as an aging population and a well-developed healthcare system, contribute to the growth of the market. Customer preferences in Austria are shifting towards advanced wound care products. Patients and healthcare professionals are increasingly seeking innovative solutions that promote faster healing and better outcomes. This is driving the demand for products such as advanced dressings, wound therapy devices, and bioactive wound care products. The market is also witnessing a shift towards personalized wound care, with products tailored to individual patient needs.The increasing prevalence of chronic wounds is another key factor driving the growth of the Wound Care market in Austria. Chronic wounds, such as diabetic foot ulcers and pressure ulcers, are becoming more common due to factors such as an aging population and the rising incidence of chronic diseases. These wounds require specialized care and advanced wound care products to promote healing and prevent complications. As a result, the demand for wound care products is expected to continue to grow in the coming years.Local special circumstances in Austria contribute to the development of the Wound Care market. The country has a rapidly aging population, with a high proportion of elderly individuals who are more prone to chronic wounds. This demographic trend is expected to drive the demand for wound care products in the coming years. Additionally, Austria has a well-developed healthcare system that provides access to advanced wound care treatments and products. This enables patients to receive the necessary care and contributes to the growth of the market.Underlying macroeconomic factors also play a role in the development of the Wound Care market in Austria. The country has a stable economy and high healthcare expenditure, which supports the demand for healthcare products and services, including wound care products. Furthermore, advancements in medical technology and research are driving the development of innovative wound care products, which are increasingly being adopted in the Austrian market.In conclusion, the Wound Care market in Austria is experiencing growth and development due to customer preferences for advanced wound care products, the increasing prevalence of chronic wounds, local special circumstances such as an aging population and a well-developed healthcare system, and underlying macroeconomic factors. The market is expected to continue to grow in the coming years, driven by these factors.
Most recent update: Mar 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights